Literature DB >> 26646105

Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells.

Crismita Dmello1, Sharada Sawant1, Hunain Alam1, Prakash Gangadaran1, Richa Tiwari1, Harsh Dongre1, Neha Rana1, Sai Barve1, Daniela Elena Costea2, Davendra Chaukar3, Shubhada Kane4, Harish Pant5, Milind Vaidya6.   

Abstract

Vimentin expression correlates well with migratory and invasive potential of the carcinoma cells. The molecular mechanism by which vimentin regulates cell motility is not yet clear. Here, we addressed this issue by depleting vimentin in oral squamous cell carcinoma derived cell line. Vimentin knockdown cells showed enhanced adhesion and spreading to laminin-5. However, we found that they were less invasive as compared to the vector control cells. In addition, signaling associated with adhesion behavior of the cell was increased in vimentin knockdown clones. These findings suggest that the normal function of β4 integrin as mechanical adhesive device is enhanced upon vimentin downregulation. As a proof of principle, the compromised invasive potential of vimentin depleted cells could be rescued upon blocking with β4 integrin adhesion-blocking (ASC-8) antibody or downregulation of β4 integrin in vimentin knockdown background. Interestingly, plectin which associates with α6β4 integrin in the hemidesmosomes, was also found to be upregulated in vimentin knockdown clones. Furthermore, experiments on lysosome and proteasome inhibition revealed that perhaps vimentin regulates the turnover of β4 integrin and plectin. Moreover, an inverse association was observed between vimentin expression and β4 integrin in oral squamous cell carcinoma (OSCC). Collectively, our results show a novel role of vimentin in modulating cell motility by destabilizing β4 integrin-mediated adhesive interactions. Further, vimentin-β4 integrin together may prove to be useful markers for prognostication of human oral cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell adhesion; Migration; OSCC; Vimentin; β4 integrin

Mesh:

Substances:

Year:  2015        PMID: 26646105     DOI: 10.1016/j.biocel.2015.11.015

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

1.  Complexes of α6β4 integrin and vimentin act as signaling hubs to regulate epithelial cell migration.

Authors:  Zachary T Colburn; Jonathan C R Jones
Journal:  J Cell Sci       Date:  2018-07-30       Impact factor: 5.285

2.  Genome-wide DNA copy number analysis and targeted transcriptional analysis of canine histiocytic malignancies identifies diagnostic signatures and highlights disruption of spindle assembly complex.

Authors:  Katherine Kennedy; Rachael Thomas; Jessica Durrant; Tao Jiang; Alison Motsinger-Reif; Matthew Breen
Journal:  Chromosome Res       Date:  2019-04-23       Impact factor: 5.239

3.  Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients.

Authors:  Crismita Dmello; Sharada Sawant; Hunain Alam; Prakash Gangadaran; Saie Mogre; Richa Tiwari; Zinia D'Souza; Manish Narkar; Rahul Thorat; Komal Patil; Devendra Chaukar; Shubhada Kane; Milind Vaidya
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

Review 4.  Intermediate Filaments at the Junction of Mechanotransduction, Migration, and Development.

Authors:  Rucha Sanghvi-Shah; Gregory F Weber
Journal:  Front Cell Dev Biol       Date:  2017-09-14

5.  Assessment of epithelial-mesenchymal transition signatures in oral submucous fibrosis.

Authors:  R Shesha Prasad; Anuradha Pai; K Shyamala; Abhishek Bhadranna; Sadhana Shenoy; Anisha Yaji
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

6.  Integrin-β4 regulates the dynamic changes of phenotypic characteristics in association with epithelial-mesenchymal transition (EMT) and RhoA activity in airway epithelial cells during injury and repair.

Authors:  Mei-Ling Tan; Wen-Jie Huang; Yue Wang; Lei Liu; Yan Pan; Jing-Jing Li; Jiang Zhang; Mingxing Ouyang; Xiang-Ping Qu; Hui-Jun Liu; Chi Liu; Dan Zeng; Xiao-Qun Qin; Linhong Deng; Yang Xiang
Journal:  Int J Biol Sci       Date:  2022-01-09       Impact factor: 6.580

Review 7.  Biomarker Potential of Vimentin in Oral Cancers.

Authors:  Saie Mogre; Vidhi Makani; Swapnita Pradhan; Pallavi Devre; Shyam More; Milind Vaidya; Crismita Dmello
Journal:  Life (Basel)       Date:  2022-01-20

Review 8.  Plectin in Cancer: From Biomarker to Therapeutic Target.

Authors:  Samantha M Perez; Lindsey T Brinton; Kimberly A Kelly
Journal:  Cells       Date:  2021-08-30       Impact factor: 6.600

9.  Effects of epiplakin-knockdown in cultured corneal epithelial cells.

Authors:  Masahide Kokado; Yuka Okada; Takeshi Miyamoto; Osamu Yamanaka; Shizuya Saika
Journal:  BMC Res Notes       Date:  2016-05-20

10.  Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial-mesenchymal transitions and facilitates early metastasis.

Authors:  Marie-Emilie Francart; Aline M Vanwynsberghe; Justine Lambert; Morgane Bourcy; Anthony Genna; Julien Ancel; Jennifer Perez-Boza; Agnès Noël; Philippe Birembaut; Ingrid Struman; Myriam Polette; Christine Gilles
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.